Wedbush Reiterates Outperform on Staar Surgical, Maintains $40 Price Target
STAAR Surgical Company (STAA) Discusses Differentiation of EVO ICL Technology and Market Trends in Refractive Surgery Transcript
STAAR Surgical Announces Participation in Upcoming Investor Conferences
5 Must-Read Analyst Questions From STAAR Surgical’s Q1 Earnings Call
STAAR Surgical signals standalone strength as Alcon overhang fades after strong Q1
STAA Q1 Deep Dive: China Momentum, Cost Discipline, and Stabilized Inventory Drive Turnaround
STAAR Surgical Q1 2026: Early Signs Of A Durable Turnaround
Wells Fargo Maintains Equal-Weight on Staar Surgical, Raises Price Target to $25
Why It's Time To Take Profits In This Top-Rated Medical Stock
STAAR Surgical (STAA) Q1 2026 Earnings Transcript
STAAR Surgical (STAA) Is Up 5.9% After Returning To Quarterly Profitability - What's Changed
Earnings To Watch: STAAR Surgical (STAA) Reports Q1 Results Tomorrow
Canaccord Genuity Maintains Buy on Staar Surgical, Raises Price Target to $32
STAAR Surgical Nearing Inflection Point for Full China Rebound, Wedbush Says
Piper Sandler Maintains Neutral on Staar Surgical, Raises Price Target to $33
Stifel Maintains Hold on Staar Surgical, Raises Price Target to $31
Wedbush Upgrades Staar Surgical to Outperform, Raises Price Target to $40
Mizuho Maintains Neutral on Staar Surgical, Raises Price Target to $27
Staar Surgical Co (STAA) Q1 2026 Earnings Call Highlights: Record Sales Surge and Return to ...
STAAR Surgical Q1 Earnings Call Highlights
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.